Aspire-Lakewood Holdings, Inc. (ASBP) SEC filings
ASBP SEC filings moved a median of -2.35% by the close. ASBP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ASBP overview →
61 measured ASBP SEC filing events.
Where these ASBP SEC filings landedvs 60 measured ASBP SEC filing reactions
| Middle 50% of ASBP SEC filing reactions | -13.33% to +1.21% |
|---|---|
| Median reaction (to close) | -2.35% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 ASBP SEC filing events with a measured close landed between -13.33% and +1.21%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aspire-Lakewood Holdings For: Sep 24 | SEC filing · Form 8-K | — | +2.33% | |
| Form 8-K Aspire Biopharma Holding For: Sep 08 | SEC filing · Form 8-K | -8.59% | -0.12% | |
| Form 8-K Aspire Biopharma Holding For: Sep 08 | SEC filing · Form 8-K | — | -0.45% | |
| Form 8-K Aspire Biopharma Holding For: Aug 19 | SEC filing · Form 8-K | -2.14% | -0.75% | |
| Form 10-Q Aspire Biopharma Holding For: Jun 30 | SEC filing · Form 10-Q | — | +10.25% | |
| Form 8-K Aspire Biopharma Holding For: Aug 06 | SEC filing · Form 8-K | -0.89% | — | |
| Form 8-K Aspire Biopharma Holding For: Jul 20 | SEC filing · Form 8-K | +0.00% | +16.18% | |
| Form 8-K Aspire Biopharma Holding For: Jun 16 | SEC filing · Form 8-K | +3.24% | +5.11% | |
| Form 8-K Aspire Biopharma Holding For: Jun 09 | SEC filing · Form 8-K | +0.10% | +12.10% | |
| Form 8-K Aspire Biopharma Holding For: Jun 12 | SEC filing · Form 8-K | +2.76% | -14.34% | |
| Form 10-Q Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | +3.36% | +18.02% | |
| Form 8-K Aspire Biopharma Holding For: May 11 | SEC filing · Form 8-K | -1.78% | -0.35% | |
| Form DEFR14A Aspire Biopharma Holding | SEC filing · Form DEFR14A | +0.00% | +5.79% | |
| Form DEF 14A Aspire Biopharma Holding For: May 08 | SEC filing · Form DEF | -8.54% | +0.36% | |
| Form PRE 14A Aspire Biopharma Holding For: Apr 27 | SEC filing · Form PRE | -1.10% | +0.24% | |
| Form 8-K Aspire Biopharma Holding For: Apr 20 | SEC filing · Form 8-K | -3.60% | -8.43% | |
| Form 8-K/A Aspire Biopharma Holding For: Apr 15 | SEC filing · Form 8-K | -2.27% | -7.32% | |
| Form 8-K Aspire Biopharma Holding For: Apr 10 | SEC filing · Form 8-K | -2.20% | -19.11% | |
| Form 8-K Aspire Biopharma Holding For: Apr 15 | SEC filing · Form 8-K | -2.27% | -7.32% | |
| Form 8-K Aspire Biopharma Holding For: Apr 16 | SEC filing · Form 8-K | -5.48% | -41.51% | |
| Form 8-K Aspire Biopharma Holding For: Apr 15 | SEC filing · Form 8-K | -5.49% | -41.48% | |
| Form EFFECT Aspire Biopharma Holding | SEC filing · Form EFFECT | -5.49% | -41.48% | |
| Form S-1/A Aspire Biopharma Holding | SEC filing · Form S-1 | — | +0.84% | |
| Form 10-K/A Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | -1.71% | +2.56% | |
| Form 10-K Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | -1.99% | +10.34% | |
| Form DEF 14A Aspire Biopharma Holding For: Feb 24 | SEC filing · Form DEF | -1.46% | +4.38% | |
| Form S-1 Aspire Biopharma Holding | SEC filing · Form S-1 | -5.70% | -1.90% | |
| Form 8-K Aspire Biopharma Holding For: Feb 06 | SEC filing · Form 8-K | -3.81% | +0.01% | |
| Form PRE 14A Aspire Biopharma Holding For: Feb 12 | SEC filing · Form PRE | +0.39% | +10.85% | |
| Form 8-K Aspire Biopharma Holding For: Feb 02 | SEC filing · Form 8-K | -0.70% | +0.70% | |
| Form 8-K Aspire Biopharma Holding For: Jan 26 | SEC filing · Form 8-K | -7.06% | -14.57% | |
| Form 8-K Aspire Biopharma Holding For: Jan 08 | SEC filing · Form 8-K | -2.16% | -6.66% | |
| Form 8-K Aspire Biopharma Holding For: Jan 07 | SEC filing · Form 8-K | +4.17% | -2.17% | |
| Form 8-K Aspire Biopharma Holding For: Jan 01 | SEC filing · Form 8-K | -11.11% | -12.28% | |
| Form EFFECT Aspire Biopharma Holding | SEC filing · Form EFFECT | -2.90% | -2.54% | |
| Form S-1 Aspire Biopharma Holding | SEC filing · Form S-1 | -3.12% | -4.09% | |
| Form 10-Q Aspire Biopharma Holding For: Sep 30 | SEC filing · Form 10-Q | -4.83% | -29.60% | |
| Form 10-Q/A Aspire Biopharma Holding For: Sep 30 | SEC filing · Form 10-Q | -3.04% | -10.49% | |
| Form 8-K Aspire Biopharma Holding For: Nov 11 | SEC filing · Form 8-K | -4.83% | -29.60% | |
| Form 8-K Aspire Biopharma Holding For: Nov 04 | SEC filing · Form 8-K | -0.03% | -24.29% | |
| Form 8-K Aspire Biopharma Holding For: Oct 15 | SEC filing · Form 8-K | +1.46% | -2.11% | |
| Form EFFECT Aspire Biopharma Holding | SEC filing · Form EFFECT | -4.10% | -38.51% | |
| Form 8-K Aspire Biopharma Holding For: Sep 22 | SEC filing · Form 8-K | -0.52% | -15.31% | |
| Form S-1/A Aspire Biopharma Holding | SEC filing · Form S-1 | -0.52% | -15.31% | |
| Form DEF 14A Aspire Biopharma Holding For: Sep 22 | SEC filing · Form DEF | +2.36% | +3.10% | |
| Form S-1 Aspire Biopharma Holding | SEC filing · Form S-1 | +0.19% | -4.36% | |
| Form PRE 14A Aspire Biopharma Holding For: Sep 08 | SEC filing · Form PRE | -4.25% | -8.40% | |
| Form 8-K Aspire Biopharma Holding For: Aug 19 | SEC filing · Form 8-K | +0.29% | +7.78% | |
| Form 10-Q Aspire Biopharma Holding For: Jun 30 | SEC filing · Form 10-Q | -3.41% | -1.64% | |
| Form 10-Q/A Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | -3.41% | -1.64% | |
| Form 8-K Aspire Biopharma Holding For: Jul 24 | SEC filing · Form 8-K | -0.10% | -12.39% | |
| Form 8-K Aspire Biopharma Holding For: Jun 17 | SEC filing · Form 8-K | -2.97% | -9.38% | |
| Form 8-K Aspire Biopharma Holding For: Jun 10 | SEC filing · Form 8-K | -2.08% | -6.62% | |
| Form EFFECT Aspire Biopharma Holding | SEC filing · Form EFFECT | -14.29% | -25.07% | |
| Form 10-Q Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | +5.29% | +0.52% | |
| Form S-1 Aspire Biopharma Holding | SEC filing · Form S-1 | -1.49% | -29.04% | |
| Form 8-K Aspire Biopharma Holding For: Apr 24 | SEC filing · Form 8-K | -1.79% | -19.87% | |
| Form EFFECT Aspire Biopharma Holding | SEC filing · Form EFFECT | +4.38% | +7.74% | |
| Form 8-K Aspire Biopharma Holding For: Apr 18 | SEC filing · Form 8-K | -3.32% | -12.99% | |
| Form S-1 Aspire Biopharma Holding | SEC filing · Form S-1 | -7.72% | +9.44% | |
| Form 10-K Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | +2.09% | -6.91% |
Keep exploring
More ASBP: earnings → · analyst actions → · ASBP overview →